Validation of an in vitro RNA processing system for CT/CGRP precursor mRNA.
AUTOR(ES)
Cote, G J
RESUMO
The pre-mRNA encoding calcitonin (CT) and calcitonin gene-related peptide (CGRP) is differentially processed in a tissue-specific fashion to include or exclude the calcitonin-specific exon 4. A minigene containing a viral first exon and exons 4, 5, and 6 from the human CT/CGRP gene was correctly processed in transfected HeLa or F9 teratocarcinoma cells to produce mRNA that included or excluded exon 4, respectively. This processing decision could be reproduced in vitro using nuclear extracts from these two cell lines and an RNA precursor from a similar minigene. Supplementation of extract from HeLa cells with extract from F9 cells resulted in the F9 splicing pattern in which exon 4 was excluded. This model system may be useful for the purification of splicing factors important in the regulation of this splice choice.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=328385Documentos Relacionados
- In vitro splicing of kappa immunoglobulin precursor mRNA.
- Comparison of in vitro and in vivo splice site selection in kappa-immunoglobulin precursor mRNA.
- Hierarchies of RNA-processing signals in a trypanosome surface antigen mRNA precursor.
- Components required for in vitro cleavage and polyadenylation of eukaryotic mRNA.
- Analysis of herpes simplex virus-induced mRNA destabilizing activity using an in vitro mRNA decay system.
